Evaluation: 2024 Essentials of the FDA Landscape for Patient Organizations Conference

Evaluation: Essentials of the FDA Landscape for Patient Organizations

Please enable JavaScript in your browser to complete this form.

What topics addressed at the conference did you find most valuable?

Session 1: Navigating FDA as a Patient Advocate With Joseph F. Lamendola, and David R. Zook
Session 2: Engaging with FDA: Opportunities and Boundaries With Shawn Shermer
Session 3: Understanding the Regulation of Cell and Gene Therapies With Eva A. Temkin and Elaine H. Tseng
Session 4: Patient Access to Other Agencies and Lawmakers With Karin Hoelzer and Cara Tenenbaum
Session 5: Accelerated Approval Expedited Pathways With Daniel A. Kracov
Session 6: Incorporating Patient Experience into Medical Product Development: Fireside Chat With Celia M. Witten and Peter J. Pitts,
Session 7: Patient Access to Treatments With Richard Klein
Session 8: Interactions with Industry: Opportunities and Boundaries With Susan Lee and Tiffany Patrick
Session 9: Hot Topics With Remy Brim, Kate Rawson, and Ryan M. Hohman

Comments?

What are the key issues you are currently facing that we could address at a future FDLI event?

Please share any additional comments:

Message

Topic Suggestions

Is there a specific topic you would like to see addressed in a future FDLI event? If so, please share your suggestions on our online portal.